Abstract
Introduction

Members of the tumour necrosis factor (TNF) family and their respective receptors play important roles in diverse cellular events, such as septic shock, induction of other cytokines, cell proliferation, differentiation and apoptosis [1, 2]. A sub-family of TNF ligands, including TNF␣, TNF-related apoptosis-inducing ligand (TRAIL) and Fas ligand
, are potent inducers of apoptosis [1, 2] . However, it has been recognized that TNF usually initiates apoptotic and antiapoptotic signals simultaneously [1, 2] . The molecular mechanisms involved in the control of survival or death in TNF signalling are under intensive investigations. [4] [5] [6] . TNFR1 activation results in stimulation of cell death pathway or activation of a protective pathway mediated by NFB, or both [4] [5] [6] [7] [8] [7] [8] [9] [10] [11] [12] [13] [14] . [7, [15] [16] [17] [18] [19] . It has been confirmed that TRADD and FADD are essential for the induction of apoptosis by TNF␣ [20, 21] . [1, 2, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Although NFB activation favours antiapoptotic signals, the activation of JNK has been regarded as an apoptotic signal (although arguments exist) [1, 2, [23] [24] [25] [26] [27] . Up [29] [30] [31] . However, there are also evidence supporting the apoptotic roles of HSP70 in receptor-mediated and stress-induced cell death [32] [33] [34] [35] [43, 44] . TNFR1 has been shown to be constitutively or inducibly associated with lipid rafts in a number of cell types [45] [46] [47] . Recently, the assembly of TNFR1-TRADD-TRAF2-RIP1 in the lipid raft has been suggested to be essential for the ubiquitination of RIP1, the recruitment of IKK complex and TAK1, the activation of NFB and the regulation of apoptosis [48] [49] [50] . In this study, we investigated the roles of HSP70 (HSP70i) in excluding TRAF2 from lipid raft via interaction and the effects of HSP70-TRAF2 interaction on TNF␣-induced signalling pathways in human colon cancer cells. 
TNF␣ exerts its function through two distinct receptors, TNFR1 (CD120a) and TNFR2 (CD120b). TNFR1 appears to be the key mediator of TNF signalling [3]. Upon binding to its ligand, TNFR1 recruits the adaptor protein TNFR1-associated death domain protein (TRADD) directly to its cytoplasmic death domain (DD), which later serves as an assembly platform for the recruitment of other molecules, such as TNFR-associated factor 2 (TRAF2) and receptor-interacting protein (RIP1) for the activation of NF-B, or Fasassociated protein with death domain (FADD) for the activation of caspase 8 and induction of apoptosis
. Previous studies have elucidated the mechanisms for the activation of NFB by TNFR1, which suggest that TRAF2 and RIP1 are major players in activating NFB by recruiting the IB␣ kinase (IKK) signalosome, a complex formed by three components: IKK␣ (IKK1), IKK␤ (IKK2) and IKK␥ (also called NEMO)
In addition to the IKK-NFB pathway, TNRF1 also signals the activation of mitogen-activated protein kinase (MAPK) pathway (including ERK1/2 [extracellular signal-regulated kinase], JNK1/2 [c-Jun N-terminal kinase]
HSP70 interacts with TRAF2 and differentially regulates TNF␣ signalling in human colon cancer cells
However, accumulating evidence have verified that the activation of NFB usually protects cells from apoptosis through regulating the expression of many intermediators involved in the regulation of apoptosis, such as Bcl-Xl, survivin, members of the inhibitor of apoptosis (IAP) family (c-IAP1, c-IAP2, XIAP) and FLICE-like inhibitory protein (FLIP) etc. [22]. The activation of both NFB and MAPK by TNFR1 is initiated by the TNFR1-TRADD-TRAF2-RIP complex
Material and methods
Cells, antibodies and reagents
Plasmids, vector construction and transfection
Western blot assay
Western blot assay was performed as described by us previously [51] . 
Sucrose density gradient centrifugation
Lipid rafts were isolated by sucrose density gradient centrifugation essentially as described [48, 50] . Cells were harvested in ice-cold PBS and lysed in 1 ml of MES-buffered saline (25 mM MES, pH 6.5, 150 mM NaCl) containing 1% Triton X-100, 10 g/ml benzamidine, 1 g/ml leupeptin, 1 g/ml pepstatin A, 5 mM NaVO4, 10 
RNA interference
For transient transfection, 21-nucleotide sequences of siRNA duplexes targeting 5Ј-GUUCCCCUUAACUUGUGACUU-3Ј (for TRAF2), 5Ј-GGUGGA-GAUCAUCGCCAACUU-3Ј (for HSP70i), 5Ј-UGAACCCCACCAACACAGUUU-3Ј (for HSC70) and the corresponding duplexes containing 3-nucleotide mutations (as
Results
HSP70i over-expression inhibits TNF␣-induced NFB activation, whereas it promotes the activation of JNK
To determine the effects of HSP70 in human colon cancer, we over-expressed Flag-tagged HSP70i in HT29 cells and LoVo cells (Fig. 1A), and then treated the cells with 20 ng/ml TNF␣. We found that HSP70i over-expression inhibited TNF␣-induced phosphorylation of IB␣ (Fig. 1B) and the nuclear translocation of p65/RelA sub-unit of NFB (Fig. 1C). Correspondingly, we found that HSP70i over-expression inhibited TNF␣-induced IKK␤ activation (Fig. 1D), NFB gene reporter expression (Fig. 1E) and NFB-regulated Bcl-xl and c-IAP1 gene expression (Fig. 1F-H). Moreover, we found that HSP70i over-expression promoted TNF␣-induced JNK activation (Fig. 1I) and p38 activation (Fig. 1J). These data indicated that HSP70i over-expression could distinguish the effects of TNF␣ on NFB and JNK activation in human colon cancer cells.
HSP70i over-expression sensitizes human colon cancer cells to TNF␣-induced apoptosis
To assess the effects of HSP70 on TNF␣-induced apoptosis, we co-transfected HSP70i-Flag and pcDNA3.1-GFP vectors in HT29 cells and treated the cells with TNF␣ for 24 hrs. We found that the transfection efficiency was about 30.4 Ϯ 3.2% (GFPpositive cells). After TNF␣ treatments, we found that cells overexpressing HSP70i showed elevated percentages of annexin V ϩ cells in GFP
ϩ populations ( Fig. 2A 
Over-expression of HSP70i promotes TRAF2 ubiquitination
Previously, it has been suggested that RIP1 but not TRAF2 was ubiquitinated in lipid rafts [48] . TRAF2 ubiquitination plays important roles in the recruitment of IKK complex and the activation of TRAF2-associated kinases [53] [54] [55] [56] . Therefore, we next examined the effects of HSP70i over-expression on the ubiquitination of TRAF2. In mock-transfected HT29 cells, TNF␣ could induce the ubiquitination of TRAF2 and RIP1
( Fig. 4A and B) . However, in HSP70i-transfected cells, we found that the ubiquitination of TRAF2 was increased, whereas the RIP1 ubiquitination was somehow decreased (Fig. 4A 
(Mann-Whitney's U-test). (C) HT29 cells were transfected with HSP70i-Flag or pcDNA3.1-Flag (Mock) vectors, treated as described in (A and B), stained with PE-annexin V and analyzed by FACS. The apoptotic cells (the annexin V-positive cells) were indicated as the percentages of whole populations. (D) ELISA assay of cleaved caspase 3 in 100 g lysates derived from mock-or HSP70-Flag-transfected cells that were treated with 20 ng/ml TNF␣ in the presence or absence of 5 M SP60025 (SP, JNK inhibitor) as indicated. Results were presented as mean OD at 450 nm Ϯ S.D. of triplicate samples. **, P Ͻ 0.01; ***, P Ͻ 0.001 (Mann-Whitney's U-test).
Fig. 3 HSP70i over-expression promotes the distribution of TRAF2 in detergent-soluble fractions and decreases the recruitment of RIP1, IKK complex and TAK1 in lipid rafts. (A) HSP70 (inducible [HSP70i] and cognate [HSC70] HSP70) as well as TNFR1, TRAF2, RIP1, TAK1 and IKK complex were recruited into lipid rafts of wild-type HT29 cells 5 min. after TNF␣ (20 ng/ml) treatments. Lipid rafts were isolated by sucrose density gradient centrifugation. The indicated components in each fraction (1-12) were examined by Western blots (equal volume of fractions was loaded). The raft-localized (Raft) caveolin-1 and the non-raft-localized (Soluble) Rab5 and transferrin receptor (TfR) were examined to display the efficiency of lipid raft isolation. (B) Western blot assay of the dynamic alterations of the indicated components within lipid rafts (combination of fractions 2-4) after TNF␣ (20 ng/ml) treatments of HT29 cells. (C) Mock (pcDNA3.1-Flag)-or HSP70i-Flag-transfected HT29 cells were treated with 20 ng/ml TNF␣ for 30 min., and then the lipid rafts (fractions 2-4 combination) and soluble fractions (fractions 10-12 combination) were isolated. The indicated components in equal volumes
were detected by Western blots. (Fig. 4D ).
Myc-tagged TRAF2 and HA-tagged ubiquitin vectors, and treated the cells with TNF␣. We found that in HEK293 cells, HSP70i over-expression could also promote the polyubiquitination of TRAF2 (Fig. 4C). Moreover, we found that TNF␣ mainly induces the K63-linked ubiquitination of TRAF2 in HSP70i-Flag-and TRAF2-Myc-co-transfected HEK293 cells since K48R (Lys48 mutated into Arg) mutate of ubiquitin could not affect the polyubiquitination of TRAF2
HSP70i interacts with the TRAF domain of TRAF2
TRAF2 can interact with diverse proteins, such as RIP1, TRADD, TAK1, ASK1 and IKK␥ via different domains [1, 2]. The above results (Figs 3 and 4) indicated that HSP70 may interact with TRAF2. In wild-type HT29 cells, we found that HSP70 (including HSP70i and HSC70) could be co-immunoprecipitated with TRAF2
Fig. 4 HSP70i over-expression promotes TRAF2 polyubiquitination but inhibits RIP1 polyubiquitination in response to TNF␣. (A, B) Mock (pcDNA3.1-Flag)-or HSP70i-Flag-transfected HT29 cells were treated with 20 ng/ml TNF␣ for 30 min. Then TRAF2 and RIP1 in cell lysates (100 g) were immunoprecipitated (IP) with TRAF2 Ab (A) or RIP1 Ab (B), respectively. Polyubiquitination was examined by immunoblotting (IB) with ubiquitin Ab and HRPlinked pre-adsorbed anti-mouse IgG. Control IgG was also used in the IP processes. (C, D) HSP70i possibly promotes K63-linked polyubiquitination of TRAF2. HEK293 cells were transiently transfected with vectors encoding HSP70i-Flag, TRAF2-Myc and HA-tagged ubiquitin (Ub-HA, C) or HA-tagged mutated ubiquitin (Lys48 mutated into Arg, UbK48R-HA, D) for 48 hrs. Then TRAF2 in cell lysates (100 g) were immunoprecipitated (IP) with Myc agarose, and the ubiquitination was examined by immunoblotting (IB) with HA Ab and HRP-linked pre-adsorbed anti-rabbit IgG. Control IgG agaroses was also used in the IP processes.
after TNF␣ treatments (Fig. 5A) . (Fig. 5C) (Fig. 5E) . Therefore, the C-terminal domain of HSP70i was responsible for its interaction with the TRAF domain of TRAF2. (Fig. 1A-E) , which may be consistent with the findings that HSP70i over-expression could disrupt the recruitment of IKK complex to lipid rafts (Fig. 3C) and partially inhibit the RIP1 polyubiquitination (Fig. 4B) [1, 2, 6-10, 13, 14, 48] (Fig. 4A) .
In HT29 cells co-transfected with TRAF2-Myc and HSP70i-Flag, we found that HSP70i-Flag could also be co-immunoprecipitated with TRAF2-Myc after TNF␣ treatments (Fig. 5B).
Next we determined the segments in HSP70i involved in interaction with TRAF2. HSP70i contains an N-terminal ATPase domain (ATPase) and a C-terminal substrate-binding domain (SBD) (Fig. 5C). In HEK293 cells co-transfected with TRAF2-Myc and
Fig. 5 HSP70i interacts with TRAF2. (A) Endogenous interaction of TRAF2 with HSP70. HT29 cells were treated with or without 20 ng/ml TNF␣ for 30 min. Then TRAF2 in cell lysates (100 g) were immunoprecipitated (IP) with TRAF2 Ab or IgG. HSP70 (HSP70i and HSC70) in the immunocomplex was examined by Western blot. (B) Exogenously over-expressed HSP70i interacts with TRAF2. HEK293 cells were transiently transfected with indicated vectors for 48 hrs. Then HSP70i-Flag in cell lysates (100 g) were immunoprecipitated (IP) with Flag agarose (Flag agar) or IgG agarose (IgG agar). Then the TRAF2-Myc contained in the immunocomplex was examined by Western blot using anti-Myc Ab. (C) Illustration of the structure of HSP70i and TRAF2 and the mutates used in the interaction assays. SBD, substrate-binding domain; RF, ring finger domain; ZF, zinc finger domain; HSP70i-C, C-terminus of HSP70i; HSP70i⌬C, deletion of the C-terminus of HSP70i; TRAF2⌬, deletion of TRAF domain in TRAF2. (D) C-terminus of HSP70i interacts with TRAF2. HEK293 cells were transiently transfected with indicated vectors for 48 hrs. Then HSP70i and the mutates in cell lysates (100 g) were immunoprecipitated (IP) with Flag agarose or IgG agarose. Then the TRAF2-Myc contained in the immunocomplex was examined by Western blot using anti-Myc Ab. The expression of the transfected vectors in cell lysates was also examined by Western blot. (E) TRAF domain of TRAF2 interacts with HSP70i. HEK293 cells were transiently transfected with indicated vectors for 48 hrs. Then TRAF2-myc and the mutates in cell lysates (100 g) were immunoprecipitated (IP) with Myc agarose or IgG agarose. Then the HSP70i-Flag contained in the immunocomplex was examined by Western blot using anti-Flag Ab. The expression of the transfected vectors in cell lysates was also examined by Western blot.
Flag-tagged HSP70i mutate vectors, we found that TRAF2-Myc could be co-immunoprecipitated with HSP70i-C-Flag but not HSP70i⌬C (deletion of C-terminal SBD) (Fig. 5D). TRAF2 contains an N-terminal ring finger domain (RF), an intermediate zinc finger domain (ZF) and a C-terminal TRAF domain
Over-expression of HSP70i promotes the oligomerization of TRAF2 and the activation of ASK1 and TAK1 induced by TNF␣
HSP70i over-expression inhibited TNF␣-induced NFB activation
because the recruitment of IKK complex into lipid rafts and the RIP1 ubiquitination may be essential for TNF␣-induced NFB activation
. However, HSP70i overexpression-mediated JNK activation in TNF␣ signalling still lacked explanations despite the observation of increased TRAF2 ubiquitination by HSP70i over-expression
To investigate the mechanisms involved in HSP70-mediated JNK activation, we first examined the activating status of ASK1 and TAK1, two major MKKKs involved in activation of JNK/p38 in TNF␣ signalling [15] [16] [17] [18] [19] , after TNF␣ treatments. We found that the levels of phosphorylated ASK1 and TAK1 were increased in HSP70i-over-expressed cells (Fig. 6A) , and the kinase activity of ASK1 and TAK1 was also increased (Fig. 6B) .
Oligomerization of TRAF2 through the TRAF domain is crucial for the activation of both NFB and JNK [57, 58] . Therefore, we examined the oligomerization of TRAF2 in detergent-soluble fractions after TNF␣ treatments in HT29 cells co-transfected with Myc-and HA-tagged TRAF2 vectors. In mock-transfected cells, the oligomerization of TRAF2 in detergent-soluble fractions was rare, whereas the oligomerization of TRAF2 in lipid rafts was strong in response to TNF␣ treatments (Fig. 6C) . However, the oligomerization of TRAF2 in the detergent-soluble fractions of HSP70i-over-expressing cells was greatly promoted (Fig. 6C) , indicating that HSP70 over-expression may facilitate the oligomerization of TRAF2 in detergent-soluble fractions.
Association of ASK1 and TAK1 with TRAF2 is involved in the activation of JNK [15] [16] [17] [18] [19] . We then examined the TRAF2-associated ASK1 and TAK1 and their kinase activity. We found that HSP70i over-expression increased the levels of TRAF2-associated ASK1 and TAK1 and the kinase activity of TRAF2-immunoprecipitated complex for recombinant MKK4 (Fig. 6D) , indicating that HSP70-TRAF2 interaction may favour the recruitment of ASK1/TAK1 and the activation of ASK1/TAK1.
To elucidate the roles of HSP70-mediated exclusion of TRAF2 from lipid raft, we examined the localization of HSP70-associated TRAF2 and TRAF2-associated phosphorylated ASK1 and TAK1. We found that the HSP70-associated TRAF2 was mainly distributed in detergent-soluble fractions, and the TRAF2-associated p-ASK1 and p-TAK1 was also in the soluble fractions (Fig. 6E) , indicating that HSP70 over-expression may favour the activation of ASK1 and TAK1 in the soluble fractions.
Silence of HSP70 does not affect the lipid raft recruitment of TRAF2 but prolongs the presence of TRAF2 in lipid raft
The above results (Fig. 3C) have suggested a potential role of HSP70 in the regulation of TRAF2 distribution in lipid raft. Therefore, we silenced HSP70 expression by siRNA duplexes specific for HSP70 (HSP70i and HSC70) (Fig. 7A) . We found that the recruitment of TRAF2 into lipid rafts 5 min. after TNF␣ stimuli was not affected by HSP70 silence, indicating that HSP70 may not be essential for the inclusion of TRAF2 in lipid rafts (Fig. 7B) . However, we found that the TRAF2 presence in lipid rafts was prolonged by HSP70 silence (Fig. 7B) , indicating that HSP70 may be required for sequestration of TRAF2 in detergent-soluble fractions. Moreover, we found that the recruitment of RIP1, TAK1 and IKK complex in lipid rafts was elevated in HSP70-silenced cells (Fig. 7B) , which may be due to the prolonged presence of TRAF2 in lipid rafts.
Silence of HSP70 inhibits TRAF2 ubiquitination
Up to now, there has been no confirmation about the cellular compartments of TRAF2 ubiquitination. To examine the effects of HSP70 on TRAF2 ubiquitination, we measured the ubiquitination status of TRAF2 in HSP70 (both HSP70i and HSC70)-silenced cells after TNF␣ treatments. We found that the TRAF2 polyubiquitination was decreased (Fig. 7C) , whereas RIP1 ubiquitination was increased (Fig. 7D ) in HSP70-silenced cells, which may be explained by the observation that HSP70 silence prolonged the presence of RIP1 in lipid raft (Fig. 7B) . Considering that lipid rafts have been shown to be essential for RIP1 ubiquitination and activation [48] [49] [50] , it may be inferred that lipid rafts may be the major sites of RIP1 ubiquitination but not of TRAF2 ubiquitination.
Silence of HSP70 promotes IKK-NFB activation but inhibits JNK activation
In HSP70-silenced cells, we found that TNF␣-induced activation of IB␣ and IKK␤ was promoted (Fig. 7E and F) , and the TNF␣-induced activation of NFB gene reporter expression was also increased (Fig. 7G) , which may be due to the elevated RIP1 ubiquitination and increased IKK complex in lipid raft (Fig. 7B and D) . On the contrary, we found that TNF␣-induced (Fig. 7H) . Fig. 2A-D) . The above data also showed that silence of HSP70 could inhibit TNF␣-induced activation of JNK but promote TNF␣-induced activation of NFB (Fig. 7E-H) . To examine the roles of HSP70 silence in TNF␣-induced apoptosis, we transiently transfected HT29 cells with siRNAs specific for HSC70 and/or HSP70i (Fig. 7A and I 
Silence of HSP70 inhibits TNF␣-induced apoptosis of human colon cancer cells
Transient over-expression of HSP70i-Flag in human colon cancer cells could promote TNF␣-induced apoptosis (
